Successful treatment of refractory peripheral T-cell lymphoma by allogeneic peripheral blood stem cell transplantation

Motoaki Shiratsuchi, Satoru Suehiro, Youko Suehiro, Kenzaburo Tani, Koichi Ohshima, Satoshi Shiokawa, Junji Nishimura

Research output: Contribution to journalArticle

Abstract

A 40-year-old man was admitted to our hospital suffering from abdominal pain. He revealed marked splenomegaly, lymphadenopathy and pancytopenia. Lymph node biopsy showed diffuse proliferation of medium to large atypical lymphoid cells. Immunohistochemically the cells were positive for T-cell markers. He was diagnosed as having peripheral T cell lymphoma (PTCL) with involvement of the spleen and bone marrow. Because of refractoriness to combination chemotherapies and splenic irradiation, we performed allogeneic peripheral blood stem cell transplantation from an HLA-identical sister. Conditioning was consisted of conventional doses of total body irradiation and cyclophosphamide, and GVHD prophylaxis was performed with cyclosporine and methotrexate. After the patient developed grade III graft-versus-host disease, his splenomegaly improved dramatically. Although the effectiveness of allogeneic hematopoietic cell transplantation in the treatment of malignant lymphoma is controversial, we should consider this as a second-line therapy to refractory subsets of PTCL.

Original languageEnglish
Pages (from-to)456-461
Number of pages6
Journal[Rinshō ketsueki] The Japanese journal of clinical hematology
Volume44
Issue number7
Publication statusPublished - Jan 1 2003

Fingerprint

Peripheral T-Cell Lymphoma
Peripheral Blood Stem Cell Transplantation
Splenomegaly
Pancytopenia
Whole-Body Irradiation
Cell Transplantation
Graft vs Host Disease
Combination Drug Therapy
Methotrexate
Cyclophosphamide
Abdominal Pain
Cyclosporine
Siblings
Lymphoma
Spleen
Lymph Nodes
Bone Marrow
Lymphocytes
T-Lymphocytes
Biopsy

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Successful treatment of refractory peripheral T-cell lymphoma by allogeneic peripheral blood stem cell transplantation. / Shiratsuchi, Motoaki; Suehiro, Satoru; Suehiro, Youko; Tani, Kenzaburo; Ohshima, Koichi; Shiokawa, Satoshi; Nishimura, Junji.

In: [Rinshō ketsueki] The Japanese journal of clinical hematology, Vol. 44, No. 7, 01.01.2003, p. 456-461.

Research output: Contribution to journalArticle

Shiratsuchi, Motoaki ; Suehiro, Satoru ; Suehiro, Youko ; Tani, Kenzaburo ; Ohshima, Koichi ; Shiokawa, Satoshi ; Nishimura, Junji. / Successful treatment of refractory peripheral T-cell lymphoma by allogeneic peripheral blood stem cell transplantation. In: [Rinshō ketsueki] The Japanese journal of clinical hematology. 2003 ; Vol. 44, No. 7. pp. 456-461.
@article{7f21e1f999724125ba2d617e9ac78b3e,
title = "Successful treatment of refractory peripheral T-cell lymphoma by allogeneic peripheral blood stem cell transplantation",
abstract = "A 40-year-old man was admitted to our hospital suffering from abdominal pain. He revealed marked splenomegaly, lymphadenopathy and pancytopenia. Lymph node biopsy showed diffuse proliferation of medium to large atypical lymphoid cells. Immunohistochemically the cells were positive for T-cell markers. He was diagnosed as having peripheral T cell lymphoma (PTCL) with involvement of the spleen and bone marrow. Because of refractoriness to combination chemotherapies and splenic irradiation, we performed allogeneic peripheral blood stem cell transplantation from an HLA-identical sister. Conditioning was consisted of conventional doses of total body irradiation and cyclophosphamide, and GVHD prophylaxis was performed with cyclosporine and methotrexate. After the patient developed grade III graft-versus-host disease, his splenomegaly improved dramatically. Although the effectiveness of allogeneic hematopoietic cell transplantation in the treatment of malignant lymphoma is controversial, we should consider this as a second-line therapy to refractory subsets of PTCL.",
author = "Motoaki Shiratsuchi and Satoru Suehiro and Youko Suehiro and Kenzaburo Tani and Koichi Ohshima and Satoshi Shiokawa and Junji Nishimura",
year = "2003",
month = "1",
day = "1",
language = "English",
volume = "44",
pages = "456--461",
journal = "[Rinsho ketsueki] The Japanese journal of clinical hematology",
issn = "0485-1439",
publisher = "Nihon Rinsho Ketsueki Gakkai/Japan Society of Clinical Hematology",
number = "7",

}

TY - JOUR

T1 - Successful treatment of refractory peripheral T-cell lymphoma by allogeneic peripheral blood stem cell transplantation

AU - Shiratsuchi, Motoaki

AU - Suehiro, Satoru

AU - Suehiro, Youko

AU - Tani, Kenzaburo

AU - Ohshima, Koichi

AU - Shiokawa, Satoshi

AU - Nishimura, Junji

PY - 2003/1/1

Y1 - 2003/1/1

N2 - A 40-year-old man was admitted to our hospital suffering from abdominal pain. He revealed marked splenomegaly, lymphadenopathy and pancytopenia. Lymph node biopsy showed diffuse proliferation of medium to large atypical lymphoid cells. Immunohistochemically the cells were positive for T-cell markers. He was diagnosed as having peripheral T cell lymphoma (PTCL) with involvement of the spleen and bone marrow. Because of refractoriness to combination chemotherapies and splenic irradiation, we performed allogeneic peripheral blood stem cell transplantation from an HLA-identical sister. Conditioning was consisted of conventional doses of total body irradiation and cyclophosphamide, and GVHD prophylaxis was performed with cyclosporine and methotrexate. After the patient developed grade III graft-versus-host disease, his splenomegaly improved dramatically. Although the effectiveness of allogeneic hematopoietic cell transplantation in the treatment of malignant lymphoma is controversial, we should consider this as a second-line therapy to refractory subsets of PTCL.

AB - A 40-year-old man was admitted to our hospital suffering from abdominal pain. He revealed marked splenomegaly, lymphadenopathy and pancytopenia. Lymph node biopsy showed diffuse proliferation of medium to large atypical lymphoid cells. Immunohistochemically the cells were positive for T-cell markers. He was diagnosed as having peripheral T cell lymphoma (PTCL) with involvement of the spleen and bone marrow. Because of refractoriness to combination chemotherapies and splenic irradiation, we performed allogeneic peripheral blood stem cell transplantation from an HLA-identical sister. Conditioning was consisted of conventional doses of total body irradiation and cyclophosphamide, and GVHD prophylaxis was performed with cyclosporine and methotrexate. After the patient developed grade III graft-versus-host disease, his splenomegaly improved dramatically. Although the effectiveness of allogeneic hematopoietic cell transplantation in the treatment of malignant lymphoma is controversial, we should consider this as a second-line therapy to refractory subsets of PTCL.

UR - http://www.scopus.com/inward/record.url?scp=0142029549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142029549&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 456

EP - 461

JO - [Rinsho ketsueki] The Japanese journal of clinical hematology

JF - [Rinsho ketsueki] The Japanese journal of clinical hematology

SN - 0485-1439

IS - 7

ER -